Finance

Lists
GERN:NASDAQ
Geron Corp
၁.၄၂ US$
-၂.၀၇%
(-၀.၀၃၀) 1D
ဇူ ၂၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GERN...
Open
၁.၄၅ US$
High
၁.၄၆ US$
Low
၁.၄၁ US$
Mkt. cap
၉၁.၁၀ ကုဋေ
Avg. vol.
၁.၂၄ ကုဋေ
Volume
၃.၂၉ သန်း
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၀
Shares outstanding
၆၄.၁၅ ကုဋေ
No. of employees
၂၅၈
Open
၁.၄၅ US$
High
၁.၄၆ US$
Low
၁.၄၁ US$
Mkt. cap
၉၁.၁၀ ကုဋေ
Avg. vol.
၁.၂၄ ကုဋေ
Volume
၃.၂၉ သန်း
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၀
Shares outstanding
၆၄.၁၅ ကုဋေ
No. of employees
၂၅၈
News stories
From sources across the web
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees၂၅၈
Founded၁၉၉၀
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitegeron.com
Analyst ratings
Based on 4 analysts giving stock ratings to GERN in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GERN in the last 3 months.
Highest
Current ၁.၄၂ US$
၅.၀၀ US$ (+၂၅၂.၁၁%)
Average
၄.၀၀ US$ (+၁၈၁.၆၉%)
Lowest
၃.၀၀ US$ (+၁၁၁.၂၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wedbush
Buy
Reiterated
၅.၀၀ US$
+၂၅၂.၁%
05/07/2026
Tara Bancroft
TD Cowen
Buy
Maintained
၃.၀၀ US$
+၁၁၁.၃%
05/06/2026
Emily Bodnar
H.C. Wainwright
Hold
Maintained
-
-
05/06/2026
Gil Blum
Needham
Buy
Maintained
၄.၀၀ US$
+၁၈၁.၇%
05/06/2026
Corinne Johnson
Goldman Sachs
Sell
Reiterated
၁.၀၀ US$
-၂၉.၆%
02/25/2026
Next call ၁၁ ရက်အတွင်း
ဩ ၅ ဗုဒ္ဓဟူး, ၁၄:၀၀
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -၀.၀၁ US$
Revenue / Est. (USD)
- / ၅.၅၃ ကုဋေ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၄.၉၀ ကုဋေ
၄.၇၂ ကုဋေ
၄.၈၀ ကုဋေ
၅.၁၈ ကုဋေ
Cost of goods sold
၂.၂၉ ကုဋေ
၂.၂၁ ကုဋေ
၁.၄၉ ကုဋေ
၁.၆၆ ကုဋေ
Cost of revenue
၂.၂၉ ကုဋေ
၂.၂၁ ကုဋေ
၁.၄၉ ကုဋေ
၁.၆၆ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၈၆ ကုဋေ
၃.၉၀ ကုဋေ
၄.၁၇ ကုဋေ
၃.၅၄ ကုဋေ
Operating expense
၃.၈၆ ကုဋေ
၃.၉၀ ကုဋေ
၄.၁၇ ကုဋေ
၃.၅၄ ကုဋေ
Total operating expenses
၆.၁၅ ကုဋေ
၆.၁၁ ကုဋေ
၅.၆၅ ကုဋေ
၅.၂၁ ကုဋေ
Operating income
-၁.၂၅ ကုဋေ
-၁.၃၉ ကုဋေ
-၈.၅၁ သန်း
-၂.၃၆ သိန်း
Other non operating income
-၆.၁၀ သောင်း
-၁.၆၁ သိန်း
-၇.၀၀ သောင်း
-၇.၄၀ သောင်း
EBT including unusual items
-၁.၆၄ ကုဋေ
-၁.၈၄ ကုဋေ
-၂.၈၉ ကုဋေ
-၃.၆၄ သန်း
EBT excluding unusual items
-၁.၆၄ ကုဋေ
-၁.၈၄ ကုဋေ
-၁.၁၈ ကုဋေ
-၄.၀၄ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၆၄ ကုဋေ
-၁.၈၄ ကုဋေ
-၂.၈၉ ကုဋေ
-၃.၆၄ သန်း
Net profit margin
-၃၃.၃၉%
-၃၉.၀၂%
-၆၀.၁၁%
-၇.၀၃%
Earnings per share
-၀.၀၂
-၀.၀၃
-၀.၀၂
-၀.၀၀
Interest and investment income
၄.၆၆ သန်း
၄.၂၆ သန်း
၄.၀၄ သန်း
၃.၄၂ သန်း
Interest expense
-၈.၅၂ သန်း
-၈.၆၄ သန်း
-၇.၃၀ သန်း
-၇.၁၅ သန်း
Net interest expenses
-၃.၈၆ သန်း
-၄.၃၈ သန်း
-၃.၂၅ သန်း
-၃.၇၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၂၃ ကုဋေ
-၁.၃၈ ကုဋေ
-၈.၄၂ သန်း
-၁.၀၂ သိန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer